If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFlowtech Fluid. Regulatory News (FLO)

Share Price Information for Flowtech Fluid. (FLO)

Share Price is delayed by 15 minutes
Get Live Data
57.00    -0.90 (-1.53%)
Bid:
57.20
Ask:
59.00
Spread: 1.80 (3.147%)
Market Cap: £46.42m
FLO Live PriceLast checked at - London Stock Exchange

Intraday Flowtech Fluid. Share Chart

Acquisition

29 Apr 2005 07:00

Flomerics Group PLC29 April 2005 29 April 2005 Flomerics Group plc ("the Company") Acquisition of Microelectronics Research & Development Limited Flomerics Group plc ("Flomerics" or "the Company"), supplier of virtualprototyping analysis software for the electronics industries announces theacquisition of the entire share capital of Microelectronics Research &Development Limited ("MicReD") for a maximum total consideration ofapproximately €2.1 million. Initial consideration is approximately €898,000, ofwhich €653,000 is payable in cash, the remaining €245,000 is satisfied by theissue of 250,663 Ordinary Shares of 1 pence each in the Company ("OrdinaryShares"), 80% now and 20% after 1 year. The deferred consideration is dependenton the financial performance of MicReD in 2005 and 2006. MicReD is a Hungarian based company and was formed in 1997 as a spin-off fromBudapest University of Technology. MicReD employs 13 people all located inBudapest and is led by the Chief Executive Officer, Marta Rencz. The managementteam of MicReD will all remain with the business. Its primary product is theT3Ster (pronounced Trister) - instrumentation and software used for measuringthe thermal performance of chip packages. Existing customers include Philips,Infineon, ST Microelectronics, Intel, Samsung and IBM. In the year to 31December 2004 MicReD had audited income of approximately €538,000 and made aprofit before tax of €288,000. In the previous year the unaudited turnover wasapproximately €123,000. The net assets at 31 December 2004 were €234,000. The semiconductor companies that make up the main target market for the T3Sterrepresent a significant, and strategically important, sector of the Flomerics'customer base. The use of the T3Ster enables them to evaluate and improve thethermal performance of chip-package designs - often alongside the complementaryuse of Flomerics' thermal analysis software. Just as the need for Flomerics'products is driven by the increasing miniaturisation and thermal densities ofelectronics devices - so exactly the same trends are driving the need for theT3Ster. The acquisition is thus strongly synergistic with Flomerics' current corebusiness, and represents a significant step for Flomerics towards providing acomplete thermal-design solution for its customers. In order to satisfy part of the initial consideration application has been madefor 200,530 new ordinary shares of 1p each to be admitted to trading on AIM witheffect from 5 May 2005. Following admission the issued share capital of theCompany will be 14,847,110 Ordinary Shares of 1p each. Commenting on the transaction David Tatchell, Flomerics' Chief Executive said "This is an important first step in delivering on our strategy of growing theCompany by acquisition in a way that complements our organic growth plans. I amdelighted to welcome into the Group the world-leading expertise that the MicReDteam bring. The T3Ster has many applications in markets where Flomerics is wellestablished, and we believe therefore that there is great potential to expandthe business." Marta Rencz said "We are very excited to be a part of the Flomerics group.Flomerics is the acknowledged standard setter in this field and theirinfrastructure will enable us to maximise the potential of our products." For further information please contact: David Tatchell Chief Executive 020 8487 3000Chris Ogle Finance Director & Company Secretary Buchanan Communications 020 7466 5000Tim Thompson / Nicola Cronk This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
10th Jul 20177:00 amRNSGroup Trading update & Notice of HY results
10th Jul 20177:00 amRNSAcquisition of Orange County Ltd, County Durham
7th Jul 201712:26 pmRNSHolding(s) in Company
23rd Jun 20177:00 amRNSFlowtech adds technical expertise & product
26th May 20171:34 pmRNSHolding(s) in Company
25th May 201711:34 amRNSResult of AGM
25th May 20177:00 amRNSAGM Statement
22nd May 201712:45 pmRNSIssue of Equity
8th May 20175:11 pmRNSHolding(s) in Company
26th Apr 20177:00 amRNSAnnual Financial Report & AGM
4th Apr 20177:01 amRNS2017 Q1 Trading Update
4th Apr 20177:00 amRNSFinal statement of results - year ended 31.12.16
30th Mar 201711:45 amRNSHolding(s) in Company
29th Mar 201711:33 amRNSResult of General Meeting
13th Mar 20176:07 pmRNSPosting of Circular
10th Mar 201711:06 amRNSConfirmation of successful £10 million fundraise
10th Mar 20177:15 amRNSClose of accelerated bookbuild
9th Mar 20175:03 pmRNSProposed Accelerated Bookbuild
6th Feb 20174:23 pmRNSHolding(s) in Company
23rd Jan 20177:00 amRNSTrading, Acquisition, Strategy & Notice of Results
20th Jan 20177:00 amRNSAppointment of Joint Corporate Broker
8th Nov 20167:00 amRNSDirector/PDMR Shareholding
21st Sep 20167:00 amRNSHolding(s) in Company
13th Sep 20167:00 amRNS2016 HALF-YEAR REPORT - SIX MONTHS TO 30 JUNE
2nd Aug 20167:00 amRNSAcquisition, Trading Update & Notice of HY Results
30th Jun 201611:54 amRNSFlowtech-winner at 2016 Regional Business Awards
2nd Jun 20167:00 amRNSGrants under the Management Incentive Plan
1st Jun 20161:40 pmRNSResult of AGM
1st Jun 20167:00 amRNSANNUAL GENERAL MEETING - TRADING UPDATE
27th May 20167:00 amRNSHolding(s) in Company
13th May 201611:51 amRNSDirector/PDMR Shareholding
6th May 20161:59 pmRNSHolding(s) in Company
3rd May 20165:23 pmRNS2015 Annual Financial Report & Notice of AGM
12th Apr 20169:10 amRNS2015 Final results - Replacement
6th Apr 201610:31 amRNSAdoption of Financial Reporting Standard (FRS) 101
26th Feb 20161:18 pmRNSHolding(s) in Company
21st Jan 20166:04 pmRNSHolding(s) in Company
19th Jan 20164:36 pmRNSHolding(s) in Company
18th Jan 20167:00 amRNSTrading Update & Notice of Annual Results
21st Dec 20157:00 amRNSHolding(s) in Company
3rd Dec 20154:11 pmRNSHolding(s) in Company
24th Nov 20157:00 amRNSShare Purchases by Directors
5th Nov 20157:00 amRNSHolding(s) in Company
4th Nov 201510:09 amRNSHolding(s) in Company
3rd Nov 20157:00 amRNSExercise of Options and Total Voting Rights
3rd Nov 20157:00 amRNSHolding(s) in Company
29th Oct 20157:13 amRNSDirector Declaration
23rd Oct 20157:00 amRNSDirectorate Change
16th Sep 20158:05 amRNSDirector's Dealings
8th Sep 20157:01 amRNSEaton - Master Trading Agreement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.